B
BBIO
Bridgebio Pharma
68.11
3.49+5.40%Pre Market: 69.70 +1.59 +2.33%08:55 11/24 EST
OPEN/PREV CLOSE64.64/64.62
TODAY RANGE64.41-69.40
VOL6.13K
MARKET CAP13.13B
52 WEEK RANGE21.72-69.48
AVG VOL (3M)2.40M
% TURNOVER2.14%
TURNOVER--
P/E (TTM)-16.2678
% RANGE7.70%
EPS(TTM)-4.1868
P/E(FORWARD)-19.3770
P/B-6.7872
BVPS-10.0350
DIVIDEND--
P/S58.33
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP11.34B
SHARES OUTSTANDING192.71M
NEXT EARNINGS02/18-02/23
FREE FLOAT166.52M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·1d ago
BridgeBio Pharma: Set For New Commercial Launches After Trial Successes
Simply Wall St·2d ago
Does Acoramidis' Survival Benefit in V142I Cardiomyopathy Shift the Bull Case for BridgeBio Pharma (BBIO)?
Simply Wall St·3d ago
BridgeBio Pharma Independent Director Wen-Chaun Lo Sells 62% Of Holding
TipRanks·5d ago
BridgeBio Pharma (BBIO) Receives a Buy from Jefferies
Simply Wall St·5d ago
BridgeBio Pharma (BBIO): Assessing Valuation After Promising Acoramidis Data at AHA and in JAMA Cardiology
Simply Wall St·11/15 15:22
BridgeBio Pharma Soars 135% as FDA Milestones Spark Valuation Debate for 2025
TipRanks·11/15 02:12
BridgeBio Pharma Director Cashes Out in a Major Stock Sale!
Same Industry
Name/Symbol
Change%
Price